About MindMed
MindMed is a company based in New York (United States) founded in 2019 by JR Rahn and Stephen L Hurst.. The company has 74 employees as of December 31, 2024. MindMed has completed 1 acquisition, including HealthMode. MindMed offers products and services including MM120 ODT and MM402. MindMed operates in a competitive market with competitors including ATAI, QurAlis, COMPASS Pathways, Passage Bio and Harmony Biosciences, among others.
- Headquarter New York, United States
- Employees 74 as on 31 Dec, 2024
- Founders JR Rahn, Stephen L Hurst
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mind Medicine (Mindmed) Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-108.68 M-13.52as on Dec 31, 2024
-
EBITDA
$-103.39 M-13.99as on Dec 31, 2024
-
Latest Funding Round
$75 M (USD), Post-IPO
Mar 11, 2024
- Investors
-
Employee Count
74
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MindMed
MindMed is a publicly listed company on the NASDAQ with ticker symbol MNMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of MindMed
MindMed offers a comprehensive portfolio of products and services, including MM120 ODT and MM402. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational drug targeting Generalized Anxiety Disorder and Major Depressive Disorder.
Drug candidate for Autism Spectrum Disorder symptoms.
Unlock access to complete
Unlock access to complete
Leadership Team
21 people
Advisor Team
16 people
Product Management Team
13 people
Software Development Team
6 people
Operations Team
6 people
Finance and Accounting
4 people
Legal and Compliance
3 people
Clinical Team
3 people
Unlock access to complete
Funding Insights of MindMed
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $75.0M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Post-IPO - MindMed | Valuation |
investors |
|
| Aug, 2023 | Amount | Post-IPO - MindMed | Valuation |
investors |
|
| Mar, 2021 | Amount | Post-IPO - MindMed | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MindMed
MindMed has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Broadway Mining. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Copper and gold deposits are explored and mined by Broadway.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MindMed
MindMed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include HealthMode. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-based wearable devices for clinical trial data collection are provided.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - MindMed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mindmed Comparisons
Competitors of MindMed
MindMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ATAI, QurAlis, COMPASS Pathways, Passage Bio and Harmony Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Drugs and CSF devices are developed for ALS treatment.
|
|
| domain | founded_year | HQ Location |
Therapies for mental disorders, including psilocybin for depression, are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapies for CNS rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for rare neurological diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mindmed
Frequently Asked Questions about MindMed
When was MindMed founded?
MindMed was founded in 2019.
Where is MindMed located?
MindMed is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of MindMed?
Stephen L Hurst is the current CEO of MindMed. They have also founded this company.
How many employees does MindMed have?
As of Dec 31, 2024, the latest employee count at MindMed is 74.
What does MindMed do?
MindMed was founded in 2019 and is headquartered in New York, United States. Psychedelic-based therapies are developed to address brain health disorders, including generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. Product candidates are advanced through rigorous scientific methods to target unmet patient needs. Research efforts span diverse therapeutic areas and mechanisms of action within the biotechnology sector.
Who are the top competitors of MindMed?
MindMed's top competitors include Harmony Biosciences, QurAlis and Passage Bio.
What products or services does MindMed offer?
MindMed offers MM120 ODT and MM402.
Is MindMed publicly traded?
Yes, MindMed is publicly traded on NASDAQ under the ticker symbol MNMD.
How many acquisitions has MindMed made?
MindMed has made 1 acquisition, including HealthMode.
Who are MindMed's investors?
MindMed has 1 investor. Key investors include Broadway Mining.
What is MindMed's ticker symbol?
The ticker symbol of MindMed is MNMD on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.